Applied Biosystems, now part of Invitrogen, was the first to pioneer a sequencing-by-ligation process, marketing it under the name of SOLiD. The process has some interesting features and is the ...

Then Applied Biosystems (ABI) introduced its next-generation sequencing machine, which was quickly followed by instruments from Illumina and Roche 454.

Applied Biosystems supplied many of the first automated sequencing machines for the Human Genome Project. The $600,000 Solid system, introduced in October, is its next-generation product.

Geospiza® and GenomeQuest will develop bioinformatics tools that are expected to advance data analysis and management for life scientists utilizing data generated by the SOLiD™ System. Geospiza has ...

Earlier this year, Applied Biosystems used the SOLiD 3 System’s underlying oligonucleotide ligation and detection technology to sequence a human genome for less than $60,000 [in 4 weeks]. Technical ...

Life Technologies's Applied BioSystems and 454 Life Sciences make up 15 percent. As I wrote a few weeks ago, Whole-genome sequencing companies are beginning to get more targeted.

Ze-Guang Han and colleagues report exome sequencing of ten hepatitis B virus–positive hepatocellular carcinomas. They identify recurrent somatic mutations in ARID1A and mutation signatures that ...

For example, Illumina acquired Solexa, ABI acquired the SOLiD technology, and Life Technologies in turn acquired ABI as well as Ion Torrent.

Applied Biosystems has announced the launch of the early-access program for its next-generation DNA sequencing system. The company said that it has shipped initial units of its SOLiD™ System to ...

Applied Biosystems has announced the worldwide commercial availability of SOLiD, the company’s next-generation DNA sequencing platform, which is expected to simplify the identification ...

The study in question used second-generation sequencing (with the ABI SOLiD system) to peer inside a single cell isolated from a mouse embryo.

Applied Biosystems expects that the SOLiD™ 3 System will enable scientists to sequence a human genome for approximately $10,000.